Singapore markets open in 28 minutes

SOPHiA GENETICS SA (SOPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.05+0.05 (+1.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 326.51M
Enterprise value 221.86M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.19
Price/book (mrq)2.16
Enterprise value/revenue 3.56
Enterprise value/EBITDA -3.19

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 36.72%
S&P500 52-week change 322.38%
52-week high 37.37
52-week low 32.13
50-day moving average 34.92
200-day moving average 34.01

Share statistics

Avg vol (3-month) 362.17k
Avg vol (10-day) 343.81k
Shares outstanding 565.3M
Implied shares outstanding 666.28M
Float 846.15M
% held by insiders 15.92%
% held by institutions 150.38%
Shares short (15 Apr 2024) 446.31k
Short ratio (15 Apr 2024) 40.58
Short % of float (15 Apr 2024) 40.10%
Short % of shares outstanding (15 Apr 2024) 40.07%
Shares short (prior month 15 Mar 2024) 443.01k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -126.63%
Operating margin (ttm)-110.98%

Management effectiveness

Return on assets (ttm)-20.78%
Return on equity (ttm)-44.93%

Income statement

Revenue (ttm)62.37M
Revenue per share (ttm)0.96
Quarterly revenue growth (yoy)27.40%
Gross profit (ttm)N/A
EBITDA -72.94M
Net income avi to common (ttm)-78.98M
Diluted EPS (ttm)-1.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.25M
Total cash per share (mrq)1.89
Total debt (mrq)18.6M
Total debt/equity (mrq)12.28%
Current ratio (mrq)4.16
Book value per share (mrq)2.32

Cash flow statement

Operating cash flow (ttm)-48.58M
Levered free cash flow (ttm)-31.34M